Historical Stock Price
BOLT historical stock prices picture
Bolt Biotherapeutics (BOLT) has the following price history information. Looking back at BOLT historical stock prices for the last five trading days, on April 22, 2024, BOLT opened at $1.11, traded as high as $1.13 and as low as $1.09, and closed at $1.11. Trading volume was a total of 39.40K shares. On April 23, 2024, BOLT opened at $1.09, traded as high as $1.12 and as low as $1.09, and closed at $1.11. Trading volume was a total of 50.50K shares. On April 24, 2024, BOLT opened at $1.10, traded as high as $1.21 and as low as $1.09, and closed at $1.20. Trading volume was a total of 154.90K shares. On April 25, 2024, BOLT opened at $1.20, traded as high as $1.21 and as low as $1.15, and closed at $1.16. Trading volume was a total of 13.30K shares. On April 26, 2024, BOLT opened at $1.20, traded as high as $1.20 and as low as $1.10, and closed at $1.11. Trading volume was a total of 122.30K shares.

BOLT Historical Stock Prices By Date:

BOLT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bolt Biotherapeutics shares, starting with a $10,000 purchase of BOLT, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/05/2021
End date: 04/26/2024
Start price/share: $32.15
End price/share: $1.11
Dividends collected/share: $0.00
Total return: -96.55%
Average Annual Total Return: -64.85%
Starting investment: $10,000.00
Ending investment: $345.34
Years: 3.22
Date Open High Low Close Volume
04/22/2024 $1.11 $1.13 $1.09 $1.11 39.40K
04/23/2024 $1.09 $1.12 $1.09 $1.11 50.50K
04/24/2024 $1.10 $1.21 $1.09 $1.20 154.90K
04/25/2024 $1.20 $1.21 $1.15 $1.16 13.30K
04/26/2024 $1.20 $1.20 $1.10 $1.11 122.30K
Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer.. Co.'s proprietary Boltbody™ ISAC (immune-stimulating antibody conjugate) platform technology combines tumor-targeting antibodies with immune-stimulating linker payloads to create productive anti-tumor immune responses. Co.'s lead product candidate, BDC-1001, is in clinical development for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-expressing solid tumors, including gastroesophageal cancer. Co.'s second program, BDC-3042, is an agonist antibody targeting Dectin-2, an innate immune receptor found on the surface of macrophages.
Date Close
04/22/2024$1.11
04/23/2024$1.11
04/24/2024$1.20
04/25/2024$1.16
04/26/2024$1.11
BOLT is categorized under the Energy sector; below are some other companies in the same sector:

BOR Historical Stock Prices
BP Historical Stock Prices
BPL Historical Stock Prices
BPZ Historical Stock Prices
BRN Historical Stock Prices
BRY Historical Stock Prices
BSM Historical Stock Prices
BT Historical Stock Prices
BTE Historical Stock Prices
BWN Historical Stock Prices

Email EnvelopeFree BOLT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


BOLT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.